TwinBeech Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
210,370
+138,348
| +192% | +$1.94M | 0.07% | 269 |
|
|
2025
Q1 | $979K | Sell |
72,022
-182,564
| -72% | -$2.48M | 0.02% | 487 |
|
|
2024
Q4 | $5.19M | Buy |
+254,586
| New | +$5.19M | 0.09% | 218 |
|
|
2024
Q2 | – | Sell |
-177,364
| Closed | -$3.64M | – | 598 |
|
|
2024
Q1 | $3.64M | Buy |
177,364
+136,784
| +337% | +$2.81M | 0.08% | 258 |
|
|
2023
Q4 | $871K | Buy |
+40,580
| New | +$871K | 0.01% | 503 |
|
|
2023
Q2 | – | Sell |
-149,302
| Closed | -$3.44M | – | 662 |
|
|
2023
Q1 | $3.44M | Buy |
+149,302
| New | +$3.44M | 0.07% | 299 |
|
|
2022
Q2 | – | Sell |
-18,046
| Closed | -$581K | – | 555 |
|
|
2022
Q1 | $581K | Buy |
+18,046
| New | +$581K | 0.03% | 383 |
|